top of page

DBP Consortium

Article 19 of the Biocidal Products Regulation states that in order to be authorised, a biocidal product should not have any immediate or unacceptable effects itself, or as a result of its residues, on the health of humans or animals, directly or through drinking water, food, feed, air, or through other indirect effects. According to Article 3 of the Biocidal Products Regulation, residue includes metabolites, breakdown and reaction products. Consequently, the ECHA Guidance on Disinfection By-Products specifies that a risk assessment of disinfection by-products ("DBPs") is necessary, as part of the authorisation of the biocidal product. Therefore, applications for biocidal products should identify the disinfection by-products profile generated during use of the biocidal product and an assessment of the identified risks from DBP generation


The DBP Consortium is an industry led effort to prepare jointly a package of common DBP profiling data for product authorisation to be used for all halogenated active substances. The aim is to produce a harmonised list of label claims (dosing regime and application conditions) that lead to a safe use, in respect to DBP generation, that applicants can reference for their own BPR authorisations.

Should you wish to become a member of the Consortium, please contact us for further information.

bottom of page